an experimental experience

11/9/22 at 6:00pm

Organization

Author

23 words

Comments

Pfizer will submit results of a phase 3 trial to the FDA soon.

You are the first to view

https://slate.com/technology/2022/11/rsv-vaccine-surge-infants-fda.html

Create an account or login to join the discussion